| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/11/2023 | 23.08% | JP Morgan | $14 → $12 | Downgrades | Overweight → Neutral |
| 08/08/2023 | 43.59% | RBC Capital | → $14 | Reiterates | Outperform → Outperform |
| 08/08/2023 | 28.21% | Barclays | $11 → $12.5 | Maintains | Equal-Weight |
| 08/08/2023 | 12.82% | Piper Sandler | $9 → $11 | Maintains | Neutral |
| 05/10/2023 | 33.33% | Oppenheimer | $11 → $13 | Maintains | Outperform |
| 05/10/2023 | 43.59% | RBC Capital | $12 → $14 | Maintains | Outperform |
| 05/10/2023 | -17.95% | Goldman Sachs | $7 → $8 | Maintains | Sell |
| 05/10/2023 | 43.59% | Raymond James | $11 → $14 | Maintains | Outperform |
| 04/24/2023 | 74.36% | JMP Securities | → $17 | Reiterates | → Market Outperform |
| 03/16/2023 | -7.69% | Piper Sandler | → $9 | Reiterates | → Neutral |
| 03/16/2023 | 23.08% | RBC Capital | $11 → $12 | Maintains | Outperform |
| 03/16/2023 | 74.36% | JMP Securities | → $17 | Reiterates | → Market Outperform |
| 03/16/2023 | 12.82% | Oppenheimer | $10 → $11 | Maintains | Outperform |
| 03/16/2023 | 2.56% | Barclays | $9 → $10 | Maintains | Equal-Weight |
| 01/23/2023 | 12.82% | Deutsche Bank | $12 → $11 | Maintains | Buy |
| 11/21/2022 | -7.69% | Piper Sandler | $11 → $9 | Downgrades | Overweight → Neutral |
| 11/14/2022 | -28.21% | Goldman Sachs | $8 → $7 | Maintains | Sell |
| 11/11/2022 | 74.36% | JMP Securities | $23 → $17 | Maintains | Market Outperform |
| 11/11/2022 | 23.08% | Canaccord Genuity | $17 → $12 | Maintains | Buy |
| 11/11/2022 | 23.08% | RBC Capital | $13 → $12 | Maintains | Outperform |
| 11/11/2022 | 12.82% | Raymond James | $15 → $11 | Maintains | Outperform |
| 11/11/2022 | -7.69% | Barclays | $17 → $9 | Maintains | Equal-Weight |
| 11/11/2022 | 43.59% | Oppenheimer | $18 → $14 | Maintains | Outperform |
| 11/11/2022 | 12.82% | Piper Sandler | $16 → $11 | Maintains | Overweight |
| 10/19/2022 | -17.95% | Goldman Sachs | → $8 | Initiates Coverage On | → Sell |
| 08/09/2022 | 64.1% | Piper Sandler | $18 → $16 | Maintains | Overweight |
| 05/10/2022 | 135.9% | JMP Securities | $26 → $23 | Maintains | Market Outperform |
| 05/10/2022 | 74.36% | RBC Capital | $20 → $17 | Maintains | Outperform |
| 05/10/2022 | 53.85% | Raymond James | $17 → $15 | Maintains | Outperform |
| 03/21/2022 | 84.62% | Stifel | $21 → $18 | Maintains | Buy |
| 03/15/2022 | 74.36% | Raymond James | $24 → $17 | Maintains | Outperform |
| 03/15/2022 | 105.13% | RBC Capital | $22 → $20 | Maintains | Outperform |
| 03/15/2022 | 84.62% | Piper Sandler | $24 → $18 | Maintains | Overweight |
| 01/27/2022 | 74.36% | Barclays | $21 → $17 | Maintains | Equal-Weight |
| 12/14/2021 | 166.67% | JP Morgan | $30 → $26 | Maintains | Overweight |
| 11/09/2021 | 166.67% | JMP Securities | $24 → $26 | Maintains | Market Outperform |
| 11/09/2021 | 166.67% | RBC Capital | $23 → $26 | Maintains | Outperform |
| 08/10/2021 | 146.15% | Raymond James | $20 → $24 | Maintains | Outperform |
| 07/26/2021 | 146.15% | Evercore ISI Group | → $24 | Initiates Coverage On | → Outperform |
| 07/26/2021 | 115.38% | Deutsche Bank | → $21 | Initiates Coverage On | → Buy |
| 07/26/2021 | 135.9% | Stifel | → $23 | Initiates Coverage On | → Buy |
| 07/26/2021 | 105.13% | Raymond James | → $20 | Initiates Coverage On | → Outperform |
| 07/26/2021 | 105.13% | Canaccord Genuity | → $20 | Initiates Coverage On | → Buy |
| 07/26/2021 | 125.64% | JMP Securities | → $22 | Initiates Coverage On | → Market Outperform |
| 07/26/2021 | 115.38% | Goldman Sachs | → $21 | Initiates Coverage On | → Buy |
| 07/26/2021 | 146.15% | Oppenheimer | → $24 | Initiates Coverage On | → Outperform |
| 07/26/2021 | 94.87% | Barclays | → $19 | Initiates Coverage On | → Equal-Weight |
| 07/26/2021 | 207.69% | JP Morgan | → $30 | Initiates Coverage On | → Overweight |
| 07/26/2021 | 115.38% | RBC Capital | → $21 | Initiates Coverage On | → Outperform |
| 07/26/2021 | 94.87% | Jefferies | → $19 | Initiates Coverage On | → Hold |
| 07/26/2021 | 125.64% | Piper Sandler | → $22 | Initiates Coverage On | → Overweight |
What is the target price for EverCommerce (EVCM)?
The latest price target for EverCommerce (NASDAQ: EVCM) was reported by JP Morgan on October 11, 2023. The analyst firm set a price target for $12.00 expecting EVCM to rise to within 12 months (a possible 23.08% upside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for EverCommerce (EVCM)?
The latest analyst rating for EverCommerce (NASDAQ: EVCM) was provided by JP Morgan, and EverCommerce downgraded their neutral rating.
When is the next analyst rating going to be posted or updated for EverCommerce (EVCM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of EverCommerce, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for EverCommerce was filed on October 11, 2023 so you should expect the next rating to be made available sometime around October 11, 2024.
Is the Analyst Rating EverCommerce (EVCM) correct?
While ratings are subjective and will change, the latest EverCommerce (EVCM) rating was a downgraded with a price target of $14.00 to $12.00. The current price EverCommerce (EVCM) is trading at is $9.75, which is out of the analyst's predicted range.